Professor Karla Arruda and Professor Marcus Maurer discuss the development and implementation of UCARE in Brazil, and its potential benefits for individuals suffering from chronic spontaneous urticaria (CSU). The conversation extends towards exploring the framework of the Brazilian UCARE centres and projects, and how it can be implemented in other countries. Professor Maurer delves into the clinical efficacy, advantages, and impact on patient quality of life of utilising Bruton’s tyrosine kinase inhibitors for the treatment of CSU, along with further discussion of alternative treatments. Access additional resources by signing up to Medthority and to be notified for future ‘All Things Urticaria’ podcast episodes!
Read more news regarding urticaria
News,webinar
March 16, 2024REGISTER NOW UCARE LevelUp Webinar: URTICARIA IN SPECIAL POPULATIONS April 23, 12:00 to 1:00 pm CET (Applied at the EACCME® for 1 CME Point) Introduction & Moderation 5’ Jason Fok [...]
New centers,News
March 15, 2024A very warm welcome to our newest UCARE Center in Germany: Universitätsklinikum Hamburg-Eppendorf (UKE)Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP) Head: Prof. Dr. Matthias Augustin Deputy: Prof. [...]
Journal Club
March 15, 2024Join us on Thursday, March 21 from 12.00 to 12.45 pm CET, for the UCARE LevelUP Journal Club! JORGE SÁNCHEZ Prof, MD, MSc, EAC, PhD (Medellin, Colombia) will speak on “Prospective analysis of the [...]
